NCT03236649 2023-02-08The Phase III Study of Icaritin Versus Sorafenib in PD-L1 Positive Advanced Hepatocellular Carcinoma SubjectsBeijing Shenogen Biomedical Co., LtdPhase 3 Terminated89 enrolled